© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Etilefrine Hydrochloride showed up on the pharmaceutical map not long after the search for better treatments for low blood pressure began picking up steam. Back in the 1960s, researchers noticed that compounds with structural similarity to adrenaline often carried interesting cardiovascular properties. Etilefrine’s introduction brought a new solution for patients struggling with hypotension when bedrest and diet alone didn’t do the job. The drug stood out for offering oral and injectable formulations that family doctors and specialists alike could actually use in daily practice. Real-world uptake took time, since physicians wanted to see evidence beyond the petri dish; evidence trickled in from European clinics, and today, etilefrine holds a legitimate place on the WHO’s Model List of Essential Medicines for certain use cases.
Etilefrine Hydrochloride belongs to the phenylethanolamine family and works as a cardiovascular stimulant. Most pharmacies recognize it under names like Effortil or Efrinol. You see it prescribed as tablets, oral drops, or ampules for injection. Symptoms targeted include chronic low blood pressure, dizziness on standing, and in some regions, support for certain heart rhythm issues. Those who’ve dealt with the wobbly legs that come with hypotension know the value of a medication that actually moves blood pressure back into a comfortable range without completely derailing the heart’s regular beat. Beyond the mainstay forms, compounding pharmacies sometimes adjust doses or suspensions for pediatric or geriatric patients with special needs.
Pure etilefrine hydrochloride shows up as a white to faintly yellowish crystalline powder, easily dissolvable in water and slightly soluble in ethanol. The molecular formula, C10H15NO2·HCl, carries a molar mass of roughly 217.7 g/mol. What separates this substance from similar adrenergic stimulants is its ability to maintain relative chemical stability when subjected to typical storage conditions, which matters greatly in regions where climate control isn’t reliable. You can smell a faint medicinal odor if you get close enough. As for handling, it doesn’t clump or cake easily under normal storage, making it easier to dose accurately.
From a technical perspective, pharmaceutical-grade etilefrine hydrochloride undergoes strict quality checks: heavy metal content, residual organic solvents, loss on drying, and identification tests by infrared and HPLC all keep batch quality on point. The labeling requirements under European Pharmacopeia and US Pharmacopeia demand not only purity levels above 98% for the active ingredient, but also clear guidance on storage, light protection, and shelf life. Blister packs and ampule strips feature QR codes in many regions today, so pharmacists quickly cross-check batch numbers and expiry dates. This level of quality assurance prevents therapeutic errors and dangerous mix-ups.
Lab synthesis starts with 3-hydroxyphenylethanol as a base substrate. A sequence of alkylation and condensation steps then introduces the ethylamino side chain, followed by hydrochloric acid treatment to generate the stable hydrochloride salt. The process stresses temperature control, since unwanted side products (such as amines and alcohol derivatives) can arise with poor heat management. Pharmaceutical manufacturing lines include multiple filtration and crystallization stages, guaranteeing high-purity product by the time the compound heads to fill-finish. The entire process leans heavily on precision—any deviation, and you get an end product either lacking activity or with impurities that could tip safety profiles.
The backbone of etilefrine gives it limited room for modification without losing therapeutic effect. Academics have tested salt swaps and esters to improve stability, but the hydrochloride version performs best in practice. Once dissolved, etilefrine remains stable over a reasonable range of pH, but alkaline environments could degrade the molecule or drive off the HCl, causing dosing errors. On the metabolic side, the body processes it mainly in the liver, using monoamine oxidase enzymes, with breakdown products departing through the urine—rarely posing risk for healthy kidneys.
You’ll find etilefrine under multiple names worldwide: Effortil, Etifel, Effordan, and in its chemical shorthand, 2-(ethylamino)-1-(3-hydroxyphenyl)ethanol hydrochloride. In hospital and pharmacy records, synonyms frequently include its anhydrous base form or just “etilefrine” for short. Different regions assign their own trade names—patients moving across borders sometimes get confused by these label changes, though the formulation inside barely changes.
Etilefrine Hydrochloride isn’t risk-free. Safety protocols run deep across manufacturing and clinical settings. Direct handling in powder form calls for gloves and respirator equipment, since accidental inhalation poses a real risk. By law, pharmaceutical plants must test every lot for residual solvents and bacterial endotoxins, both of which could threaten patient health. On the prescriber side, national formularies flag etilefrine for use only in patients without severe cardiac disease, hyperthyroidism, or certain arrhythmias. Overdose brings classic symptoms: hypertension, palpitations, severe headache, and fits of anxiety. That said, with proper training and tracking, the risks shrink considerably in daily medical use.
Doctors reach for etilefrine when patients don’t react to conservative management of low blood pressure, or in cases of neurogenic orthostatic hypotension. It finds utility in critical care when blood pressure needs a boost but full-strength catecholamines like norepinephrine would be overkill. Athletes and those with “performance anxiety” sometimes misuse the drug for off-label energy, leading to regulatory scrutiny. In veterinary settings, some regions add etilefrine to protocols for animals in shock or surgery—the principles largely mimic those for human patients.
Current research puts the spotlight on whether etilefrine could have a bigger footprint in the management of chronic fatigue or postural tachycardia syndromes, both fields where established options lag behind patient needs. A handful of clinical trial groups are assessing drug delivery modifications, like sustained-release tablets and transdermal patches, to cut down on side effects. In the arena of molecular medicine, some investigators search for analogs that act on the same receptors but clear the system faster, hoping to reduce negative cardiovascular outcomes. Academic and industry research collaborations show promise, but funding remains tricky since etilefrine sits off-patent in most countries.
Toxicologists track data from both animal studies and decades of use in human medicine. Acute toxic doses cause a jump in blood pressure and uncontrolled heart rates in rodent models, leading to recommendations for narrow therapeutic windows in humans. Chronic exposure studies show minimal long-term risk when therapy follows labeled instructions. Still, rare reports of arrhythmias, heart strain, or allergic reactions pop up in pharmacovigilance databases and can’t be ignored. Regulatory agencies keep an eye on population-wide trends, especially in parts of Asia where over-the-counter sales cloud the real picture of misuse and side effects. Most poison control guidance still centers on activated charcoal and observation, unless complications set in.
Looking ahead, demands for new, affordable cardiovascular drugs will drive interest in etilefrine as a reliable standby. Digital health and telemedicine create fresh pathways for monitoring response in outpatient settings—doctors can keep tabs on daily blood pressure shifts and adjust doses in real time. Personalized medicine opens doors to predictive screening: knowing who metabolizes etilefrine too quickly or too slowly could sharpen dosing accuracy. Industry insiders anticipate that improvements in manufacturing and drug delivery will push side effects lower and help the drug reach lower-income communities where hypotension still costs lives. Given the changing landscape of chronic disease and the move toward patient-centered care, etilefrine has a role to play if it can keep pace with emerging expectations in safety, accessibility, and innovation.
Etilefrine hydrochloride isn’t a medicine you bump into every day at the pharmacy, but in hospital wards and some doctors’ offices, it holds real value for those living with certain conditions. This drug mostly goes to work for folks with low blood pressure, especially the kind that hits when standing up too quickly—a problem known as orthostatic hypotension. Dizziness, fainting, feeling wiped out after even standing still for just a few minutes: all these are hurdles people face with low blood pressure. I’ve seen people struggle to get through a day’s work or even shop for groceries because they feel like the floor is tilting beneath them. In those moments, etilefrine steps in where a glass of water and a salty snack simply won’t cut it.
This medication works by tightening up blood vessels, helping the heart send blood up to the brain. The result can mean fewer dizzy spells and a steadier feeling of energy. As somebody who has spent years talking to patients with chronic blood pressure swings, I’ve watched the toll it takes on a person’s confidence and ability to lead a normal life. For many, etilefrine’s effects aren’t just a boost in numbers—they’re a ticket back to feeling steady on their feet.
Plenty of useful drugs come with caveats. Etilefrine can raise heart rate and blood pressure, sometimes to an unhealthy level if not closely monitored. Anyone with a history of heart problems, arrhythmias, or uncontrolled high blood pressure needs special attention if prescribed this medication. In my view, drugs like this demand conversation, not just prescription slips. It’s not enough to hand out a bottle—the whole story has to be understood and tracked over time. Monitoring and patient education keep unpleasant surprises at bay. Side effects, such as palpitations, headaches, or feelings of anxiety, do hit some people. That’s why follow-up and honest communication matter between patients and caregivers.
Most patients never hear about etilefrine unless their blood pressure numbers stubbornly refuse to stay up, even after trying other methods. Salt tablets, compression stockings, plenty of fluids—these all form the foundation for many people. Doctors usually reserve medicines like etilefrine for tougher cases, and always after checking every possible risk. Guidance from a health professional weighs heavily here, since overdoing it leads to new problems.
People struggling with “blackout” moments or sudden weakness just want relief. Personally, I wish more folks reached out sooner, because chronic low blood pressure isn’t just inconvenient; it robs people of their sense of safety. Etilefrine fills a gap when lifestyle changes and other simple fixes don’t work. The medicine alone won’t build a safety net, though. Clear instructions, steady check-ups, and considering heart health from all angles create the real foundation for improvement.
Struggling with daily symptoms deserves more than a shrug or a wait-and-see approach. Involving a care team, using clear language, and making sure people know both benefits and risks—that’s what gives this drug an important role in the right hands. Solutions reach farther if both patients and doctors keep the conversation open, weigh all the facts, and tackle challenges as a team.
Etilefrine Hydrochloride helps people with low blood pressure get back on their feet, literally. Doctors turn to this medication for heart and circulatory troubles, especially in folks who experience dizzy spells or even brief “blackouts” when they stand up. The drug boosts blood pressure by nudging the heart to pump a little harder and tightening up the blood vessels.
No medication comes free from side effects. With Etilefrine Hydrochloride, the most common gripes seem to hit the heart and head. People sometimes talk about feeling their pulse racing, and the science backs that up: increased heart rate and palpitations top the list. Headaches come next in line—likely from those blood vessels tightening up. Nervousness or jitters, along with a sense of anxiety, also make appearances, especially in folks sensitive to heart stimulants. These issues might sound minor, but anyone who’s ever tried working through a pounding head or racing heartbeat knows how these symptoms shake up a day.
Other common reactions involve the stomach. Nausea pops up for some, sometimes paired with the feeling you could lose your lunch at any moment. Dry mouth follows, and a few people run into stomach cramps or mild digestive trouble. These might not steer everyone away from the medicine, but they add to daily discomfort. I’ve watched patients grit their teeth through symptoms simply because the medication keeps their blood pressure in check, but this barely counts as a win if you can’t go about a normal day without interruption.
Some side effects force a hard decision. Chest pain or shortness of breath prompt a call to the clinic, not just a shrug and push-through. These red flags may hint at real trouble—arrhythmias or even worsening heart function. Another risk: people with diabetes have to monitor blood sugar a bit closer, since the medication’s effects on stress hormones can mess with glucose levels. From personal experience in the clinic, explaining these risks—and listening when patients talk about side effects—makes a big difference in trust and adherence.
Published studies and patient data show that most people can handle the average side effects, but some have to stop the drug after repeated racing heartbeats, sweating, or headaches. A survey of peer-reviewed research points toward these known issues, though severe reactions remain rare. Regulators in countries with stricter pharmacovigilance watch for cardiovascular events or allergic responses, especially in people with a history of heart disease.
Several possible fixes stand out. Doctors can start people on the lowest practical dose, adjusting upward only if lightheadedness sticks around. Taking the tablet with food sometimes helps the stomach troubles. Daily blood pressure tracking lets both patient and physician catch any sudden swings before a fall or a trip to the ER. Most importantly, honest conversation between doctor and patient builds a path to safer use—and better overall results.
Real-world success with Etilefrine Hydrochloride depends on balancing its benefits with known drawbacks. Side effects can feel mild or maddening, and everyone’s tolerance looks a little different. By staying alert for warning signs and leaning on honest communication, people can get real help for persistent low blood pressure, while sidestepping most trouble on the journey.
Many people dealing with low blood pressure end up talking about etilefrine hydrochloride. From my dad’s years managing hypotension, I can tell you—understanding how to take this medicine matters just as much as knowing what it does. The goal is to help the body find balance, not swing from one extreme to the other.
Don’t eyeball the dose or just take a friend’s advice. Doctors come up with individual plans after weighing up a person’s age, condition, and how their body reacts to other meds. Standard advice points toward swallowing the tablet whole with a glass of water, often before meals. Skipping food while taking etilefrine gives the medicine a better shot at working without irritation. My father found that sticking to the routine, usually in the morning, kept his blood pressure stable and his energy up.
Changing up the dose or mixing it in with juice without talking to your doctor—mistake. Etilefrine isn’t the kind of medicine you adjust yourself. Some folks might need a lower dose because of how their liver or kidneys work. That’s why all new starts, stops, or changes go through a healthcare professional. Regular blood pressure checks often keep surprises at bay.
Keeping tablets away from damp spots like bathrooms or sunny kitchen counters keeps them safe to use. After he left his pills in the car one summer day, my dad learned firsthand that heat can spoil them. Most packaging mentions storage in a cool, dry spot—there’s a reason for that. Also, setting up pill organizers or phone alarms keeps missed doses rare.
If you do forget once, don’t double up to catch up. Doubling a missed dose can cause a sharp spike in blood pressure—sometimes enough to send you to the ER. Instead, resume your usual routine and talk with your doctor if you’re missing tablets more than once in a while.
Etilefrine can trigger headaches, a racing heartbeat, or nervousness, especially when you just start. My father took note of any new feelings and kept a log. If he got dizzy or his heart felt odd, he talked to his provider before taking the next dose. You want your care team in the loop with new symptoms.
Other prescription drugs and even over-the-counter cold pills might clash with etilefrine. These mixes can lead to unpredictably high blood pressure. Bringing a current medication list to doctor visits helps catch those risks early.
There’s plenty of misinformation online, but real safety comes from proven sources and good medical advice. The European Medicines Agency, reputable clinics, and the prescribing leaflet hold more weight than a search engine rumor. If ever in doubt—ask the pharmacist or doctor, not social media.
Staying hydrated, eating a balanced diet, getting enough sleep, and checking blood pressure at home all matter alongside etilefrine. The medicine forms part of a bigger picture, not the whole solution. Practical routines and open communication with a healthcare team build a safer path for anyone relying on this prescription.
Etilefrine hydrochloride helps people with conditions like orthostatic hypotension, where blood pressure falls suddenly during standing. It works by tightening blood vessels and stimulating the heart, which can make a real difference for patients who often feel dizzy or faint. Doctors prescribe it with a specific goal—restoring blood flow to important organs and making everyday life safer.
Medications rarely work in isolation. For someone living with chronic health conditions, mixing drugs comes with real risks. I’ve seen people come into clinics not because their main condition caused trouble but because their combination of meds triggered side effects. Etilefrine acts like adrenaline in the body, so drugs that influence blood pressure, heart rhythm, or the nervous system can disrupt its work or make its actions unpredictable.
Beta-Blockers and EtilefrineDoctors sometimes prescribe beta-blockers for high blood pressure or heart issues. Taking them together with etilefrine can confuse the body. Beta-blockers slow down the heart and relax blood vessels. Etilefrine tries to do the opposite. This clash can blunt the benefits of both drugs and sometimes cause sharp swings in blood pressure.
Monoamine Oxidase Inhibitors (MAOIs)MAOIs, used for certain mood disorders, can boost the effects of etilefrine. The risk is that blood pressure can shoot dangerously high. Stories exist of patients ending up in the emergency room from serious headaches, pain behind the eyes, or even seizures after these drugs met in the bloodstream.
Other Blood Pressure MedicinesMixing etilefrine with other antihypertensives, like ACE inhibitors or calcium channel blockers, sometimes makes treatment less effective. The body gets mixed signals. With both stimulation and relaxation happening, blood pressure can become hard to manage, sometimes swinging too low or spiking unexpectedly.
Heart Rhythm MedicationsSome drugs control irregular heartbeats by altering electrical activity in the heart. Etilefrine can counter their effects, making these conditions harder to treat. Rapid heartbeat, skipped beats, and dizziness become more likely when these mixes aren’t monitored carefully.
Anyone living with diabetes should talk with their provider before starting etilefrine. Stimulant medicines can hide signs of low blood sugar, which puts people at risk if they don’t notice warning symptoms. The impact extends to people with thyroid disease, prostate issues, or eye conditions like glaucoma—each can experience worsened symptoms or new problems from these drug combinations.
Doctors and pharmacists play crucial roles here. They should check every new prescription against other meds a person takes. Electronic medical records help, but it’s still wise for patients to bring a full list of their prescriptions and over-the-counter pills. Conversations about supplements and herbal remedies matter, too. St. John’s wort, ginseng, and other herbal products have been shown to interact with blood pressure drugs in unpredictable ways.
Medical teams need ongoing updates from patients if dizziness, weakness, or palpitations start after a new prescription. Real-world vigilance—around family dinners or at the pharmacy counter—prevents most of the serious stories linked to drug interactions.
Every prescription comes with a story. The right questions and clear communication stand out as some of the best ways to stay safe. Health outcomes improve when nobody feels rushed, and the pharmacist or doctor walks through all the risks from the start. That’s an approach I’ve seen change outcomes in hospital wards, clinics, and neighborhoods alike.
Etilefrine Hydrochloride falls in the group of medicines that support blood pressure, especially for those struggling to keep it high enough. This drug finds use in treating certain types of low blood pressure, especially in some heart and nerve-related conditions. Over the past few years, questions have popped up about its safety, especially for users who already deal with longstanding health conditions.
People battling heart disease carry a bigger risk with this medication. If someone has been through a recent heart attack or fights ongoing chest pain, etilefrine can push the heart too hard. Arrhythmias—irregular heartbeats—present an especially real concern here. According to cardiology reports, drugs that raise blood pressure often raise the risk of dangerous heart rhythms and strain on weakened heart muscle. From my years watching family members manage heart disease, I’ve seen the consequences of ignoring these risks. Medicines safe for one person can flip on another, especially with heart issues in the mix.
If blood pressure already runs too high, adding etilefrine creates further danger. Unchecked hypertension increases the chances for stroke, heart failure, damage to blood vessels, or even bleeding in the brain. Data from the American Heart Association points to the dangers of pushing blood pressure even higher in people already at or above the recommended range. Mixing medications, especially as someone ages, can sneak blood pressure to unsafe levels. Regular check-ins with a doctor and home monitoring go a long way to catch these issues early.
People with overactive thyroid conditions, such as hyperthyroidism, should watch out. Etilefrine stimulates the body in ways that can worsen the rapid heart rate or nervousness these patients feel. Eye conditions in which pressure rises inside the eye—such as narrow-angle glaucoma—also create a no-go zone for this medication. Stories surface again and again of people tipping into a health crisis by mixing incompatible pills and eye drops. Healthcare professionals flag this combination for good reason. Safety checks in the pharmacy and clear labeling can save someone’s eyesight.
Folks living with diabetes walk a tightrope. Etilefrine can raise blood sugar, sometimes without warning. During my time volunteering in diabetes support groups, I heard stories of blood sugar suddenly spiking after a medication change. It’s easy to pay attention to diet, but sometimes we forget our prescriptions affect sugar control just as much. For people on insulin or other drugs that lower blood sugar, adding another variable makes management harder. It’s important to tell your doctor about every new symptom, even if it seems unrelated.
Safety studies for etilefrine during pregnancy don’t offer much reassurance. Evidence so far can’t guarantee safety for developing babies, so most doctors recommend safer options for managing blood pressure while pregnant. Pediatric use also stays limited. Children's bodies don’t always process medicine in the same way, and careful monitoring by a specialist matters far more for young patients.
Etilefrine Hydrochloride has its place for some serious conditions, but plenty of people would do better with an alternative. Upfront conversations with doctors and pharmacists about your whole health picture—heart, eyes, thyroid, blood sugar, and more—make all the difference. A careful review of every prescription could be a lifesaver. If any doubts linger, getting a second opinion cuts through confusion, especially when it comes to complicated medication choices.
| Names | |
| Preferred IUPAC name | 1-(4-hydroxyphenyl)-2-(ethylamino)propan-1-ol hydrochloride |
| Other names |
Etilefrine HCl Effortil Etilefrinum hydrochloricum Etilefrine hydrochloride Etilefrina clorhidrato Etilefrinum Etilefrina |
| Pronunciation | /ˌɛtɪˈliːfrɪn haɪˌdrɒklaɪˈraɪd/ |
| Identifiers | |
| CAS Number | 33124-50-4 |
| 3D model (JSmol) | `Etilefrine Hydrochloride` 3D model (JSmol) string: ``` [H][C@@](O)(c1ccc(O)cc1)CNCCCCCl.Cl ``` This is the SMILES string for Etilefrine Hydrochloride that can be used in JSmol to generate the 3D model. |
| Beilstein Reference | 1415314 |
| ChEBI | CHEBI:4815 |
| ChEMBL | CHEMBL2104526 |
| ChemSpider | 2158 |
| DrugBank | DB08965 |
| ECHA InfoCard | ECHA InfoCard: 10004038-01-3 |
| EC Number | 214-210-6 |
| Gmelin Reference | 69050 |
| KEGG | D07914 |
| MeSH | D004572 |
| PubChem CID | 71920 |
| RTECS number | KH2975000 |
| UNII | def2FA6G9W |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID4040916 |
| Properties | |
| Chemical formula | C10H16ClNO2 |
| Molar mass | 328.87 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.16 g/cm³ |
| Solubility in water | Soluble in water |
| log P | 0.01 |
| Vapor pressure | 6.08E-13 mmHg at 25°C |
| Acidity (pKa) | 8.66 |
| Basicity (pKb) | 7.3 |
| Magnetic susceptibility (χ) | -85.5×10⁻⁶ cm³/mol |
| Dipole moment | 2.51 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 240.8 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | C01CA02 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS07, Warning, H302, H312, H315, H319, P261, P264, P270, P280, P301+P312, P302+P352, P305+P351+P338, P332+P313, P337+P313, P362+P364 |
| Pictograms | GHS02, GHS07 |
| Signal word | Warning |
| Hazard statements | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Precautionary statements: If medical advice is needed, have product container or label at hand. Keep out of reach of children. Read label before use. Avoid release to the environment. |
| Flash point | 98.2°C |
| Lethal dose or concentration | LD50 (oral, rat): 215 mg/kg |
| LD50 (median dose) | LD50 (median dose): 30 mg/kg (mouse, intravenous) |
| NIOSH | RTECS SF5950000 |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 10 mg |
| Related compounds | |
| Related compounds |
Phenylephrine Synephrine Metaraminol Methoxamine Norepinephrine Epinephrine Dopamine |
